أكاديمية التأثير العلمي | Impact Academy retweeted
🎓 That's a wrap on #DiabetesMasterClass2026!
👥 130+ participants
🔴 26+ hours live
🎙️ 9 expert speakers
📝 600+ questions shared
🌟 95%+ satisfaction
Thank you to our faculty and to everyone who made this journey possible 🙏🏻💙
أكاديمية التأثير العلمي | Impact Academy retweeted
10 evenings. 9 experts. One masterclass. 🎓
That's a wrap on #DiabetesMasterClass2026. Thank you to our faculty and to all 130+ participants 🙏🏻💙
أكاديمية التأثير العلمي | Impact Academy retweeted
No weight loss on semaglutide ≠ no benefit. 💊
SELECT (17,000+ patients): those who lost < 5% had the same CV risk reduction as those who lost ≥ 5%.
Similar weight-independent effects in MASH.
Dr Ali Alshehri · Session 10
#DiabetesMasterClass2026 #Semaglutide
أكاديمية التأثير العلمي | Impact Academy retweeted
Diabetes remission at 5 years (STAMPEDE) 🔁
Gastric bypass ~30%
Sleeve, close behind
Medical therapy 5%
DiRECT: 46% at 1 year → 36% at 2 years.
Relapse is biology, not patient failure.
Dr Ali Alshehri · Session 10
#DiabetesMasterClass2026 #DiabetesRemission
أكاديمية التأثير العلمي | Impact Academy retweeted
Normal HbA1c on a GLP-1 ≠ remission. ⚠️
Remission = HbA1c < 6.5% off ALL glucose-lowering meds for ≥ 3 months.
And it's not a cure: keep screening for complications.
Dr Ali Alshehri · Session 10
#DiabetesMasterClass2026 #DiabetesRemission
أكاديمية التأثير العلمي | Impact Academy retweeted
Steno-2: treat glucose, BP and lipids together in type 2 diabetes. ⏳
All-cause mortality −46%
CV death −57%
HF hospitalization −70%
+7.9 years of life
Dr Mohammed Almehthel · Session 9
#DiabetesMasterClass2026 #Steno2
أكاديمية التأثير العلمي | Impact Academy retweeted
Is lower HbA1c always better? ACCORD said no. 📉
Intensive arm (< 6%): no significant CV benefit, mortality +22%, stopped early.
Long-standing T2D + CVD: don't chase < 6.5%.
Newly diagnosed, no CVD: < 6.5% can still help.
Dr Mohammed Almehthel
#DiabetesMasterClass2026 #ACCORD
أكاديمية التأثير العلمي | Impact Academy retweeted
They didn't wait for the industry. They built it. 🔁
Open-source AID = approved CGM + approved pump + a phone app.
30,000+ users worldwide.
ADA 2025: support people who choose it (level B).
Not approved by any regulator, and not for everyone.
#DiabetesMasterClass2026
أكاديمية التأثير العلمي | Impact Academy retweeted
High every morning, zero carbs. 🌅
Not Somogyi (no 3–4 am hypo).
Not dawn (no gradual rise from 3–4 am).
FOG, "Feet On the Ground": a spike on waking from a hormone surge.
Don't raise the basal; it only adds hypo risk.
Dr Ali AlQahtani · Session 8
#DiabetesMasterClass2026 #T1D
أكاديمية التأثير العلمي | Impact Academy retweeted
Reading an AGP report 📊
1. ≥70% sensor wear
2. Hypos first
3. TAR, mean, variability
4. Find the pattern
Post-meal highs? Check carb counting and bolus timing before touching the carb ratio.
Dr Ali AlQahtani · Session 8
#DiabetesMasterClass2026 #CGM
أكاديمية التأثير العلمي | Impact Academy retweeted
LDL 53 after an MI. At goal? 🩸
Non-HDL 95. ApoB 85. TG 340.
In diabetes, small dense LDL can make LDL-C look falsely low. Check non-HDL + ApoB, then intensify.
Dr Abdulrahman Mashi · Session 7
#DiabetesMasterClass2026 #ApoB
أكاديمية التأثير العلمي | Impact Academy retweeted
Doubling a statin dose → only ~6% more LDL lowering. 📉
Pick the add-on by the gap:
Gap ≤20–25% → ezetimibe
Gap >20–25% → straight to a PCSK9 inhibitor
Dr Abdulrahman Mashi · Session 7
#DiabetesMasterClass2026 #LDL
أكاديمية التأثير العلمي | Impact Academy retweeted
BP in diabetes, 2026 🩺
Treat at ≥130/80. Goal <130/80.
High CV/kidney risk: systolic <120 if safe.
BPROAD: <120 vs <140 → 21% fewer CV events.
≥150/90 → start 2 drugs, ideally one pill.
Dr Abdulrahman Mashi · Session 7
#DiabetesMasterClass2026 #Hypertension
أكاديمية التأثير العلمي | Impact Academy retweeted
De-intensify ≠ simplify 👴
De-intensify: control too tight → reduce the burden
Simplify: regimen too complex → fewer pills or shots, whatever the HbA1c
82 y, HbA1c 6.4% on glimepiride? Stop it and relax the target to 7.5–8%.
DrSaqib Ali
#DiabetesMasterClass2026 #Geriatrics
أكاديمية التأثير العلمي | Impact Academy retweeted
SGLT2 inhibitors in CKD: remember C-D-E 🧠
Canagliflozin: start at eGFR ≥30
Dapagliflozin: ≥25
Empagliflozin: ≥20
Below 20: none
Below eGFR 45, glucose lowering is reduced.
Dr Saqib Ali · Session 6
#DiabetesMasterClass2026 #CKD
أكاديمية التأثير العلمي | Impact Academy retweeted
Suspect type 1? Write insulin.
A patient switched to Mounjaro privately → ICU with severe DKA.
And type 1 + hypertension? Rule out DKD/CKD first (~90%), then double diabetes, then secondary causes.
Dr Saqib Ali · Session 6
#DiabetesMasterClass2026 #T1D
أكاديمية التأثير العلمي | Impact Academy retweeted
Ask every woman with diabetes, at every visit:
"Would you like to become pregnant in the next year?" 🤰
Pre-pregnancy HbA1c 6.5% → 4% anomaly risk
9% → 6%
12% → 12%
NNT = 17 to prevent one anomaly.
Dr Balsam Bohlega · Session 6
#DiabetesMasterClass2026 #DiabetesInPregnancy
أكاديمية التأثير العلمي | Impact Academy retweeted
Pregnant on a GLP-1 RA? Don't panic. Plan. 🤰
• Advice: stop 2 months before conception
• JAMA IM, 50,000+ women: no higher risk of major anomalies vs insulin
• But stopping with no alternative → weight gain + hyperglycemia
Dr Balsam Bohlega
#DiabetesMasterClass2026 #GLP1
أكاديمية التأثير العلمي | Impact Academy retweeted
Positive pregnancy test on metformin? Don't stop it yet.🤰
"Stop all your meds" → 2–3 weeks unseen → glucose shoots up.
Hyperglycemia in the first 12 weeks is the bigger danger. Bridge with metformin, then decide.
DrBalsam Bohlega
#DiabetesMasterClass2026 #DiabetesInPregnancy
أكاديمية التأثير العلمي | Impact Academy retweeted
Type 1 diabetes is a full-time job. 💙
42+ factors affect glucose. 180–300 health decisions a day. 1,000–2,000 injections a year. 30–40% face mental health problems.
Dr Mohammed Almehthel · Session 5
#DiabetesMasterClass2026 #T1D



